Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. with emergence of multidrug-resistant strains

Iranian Journal of Public Health

Volumn 39, Issue 2, 2010, Pages 63-68

  Moniri, R ^a   Farahani, R Kheltabadi ^a   Shajari, Gh ^a   Shirazi, M H Nazem ^b   Ghasemi, A ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Molecular Biology   (Iran)

Author keywords

Acinetobacter spp.; Aminoglycoside resistance genes; Antibiotic resistance; Iran; PCR gene detection

Indexed keywords

EID: 77954065912     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Magnet S, Courvalin P, Lambert T (2001). Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454. Antimicrob Agents Chemother, 45(12): 3375-80.
2. Mak JK, Kim MJ, Pham J, Tapsall J, White PA (2009). Antibiotic resistance determinants in nosocomial strains of multidrugresistant Acinetobacter baumannii. J Antim-icrob Chemother, 63(1): 47-54.
3. Lambert T, Rudant E, Bouvet P, Courvalin P (1997). Molecular basis of aminoglycoside resistance in Acinetobacter spp. J Med Mi-crobiol, 46: 731-35.
4. Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, et al. (1993). In vitro antimicrobial production of beta-lactamases, ami-noglycoside-modifying enzymes, and chloram-phenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 37:138-41.
5. Miller GH, Sabatelli FJ, Naples L, Hare RS, Shaw KJ (1995). The most frequently occurring aminoglycoside resistance mechanisms- combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. J Chemother, 7(Suppl. 2): 17-30.
6. Seward RJ, Lambert T, Towner KJ (1998). Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J Med Micro-biol, 47: 455-462.
7. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L (2004). Diversity of ami-noglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol, 53(Pt 12):1233-40.
8. Gombac F, Riccio ML, Rossolini GM, Laga-tolla C, Tonin E, Monti-Bragadin C, et al. (2002). Molecular characterization of inte-grons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob Agents Che-mother, 46: 3665-68.
9. Ribera A, Vila J, Fernandez-Cuenca F, Martinez-Martinez L, Pascual A, Beceiro A, et al. (2004). Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother, 48: 364-65.
10. National Committee for Clinical Laboratory Standards (2000). Performance standards for antimicrobial disk susceptibility tests. Approved standard, 7th ed, document M2-A7. NCCLS, Wayne, PA, USA.
11. Hujer KM, Hujer AM, Hulten EA, Bajak-souzian S, Adams JM, Donskey CJ, et al. (2006). Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother, 50(12): 4114-23.
12. Lu Q, Huang LS, Zhang R, Xu GB, Zhao XY (2008). Following-up of nosocomial lower respiratory infection in patients with hematological malignance after chemotherapy. Zhonghua Yu Fang Yi Xue Za Zhi, 42(2): 123-26.
13. Giamarellou H, Antoniadou A, Kanellako-poulou K (2008). Acinetobacter bauman-nii: a universal threat to public health? Int J Antimicrob Agents 32(2):106-19.
14. Gaur A, Garg A, Prakash P, Anupurba S, Mohapatra TM (2008). Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr, 26(2):183-88.
15. Shaw KJ, Rather PN, Hare RS, Miller GH (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev, 57:138-63.
16. Shiri N-V, Ronen B-A, Yehuda C (2005). Update on Pseudomonas aeruginosa and Acine-tobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis, 18: 306-13.
17. Van Looveren M, Goossens H (2004). AR-PAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect, 10: 684-704.
18. Cisneros JM, Rodriguez-Bano J, Fernandez-Cuenca F, Ribera A, Vila J, Pascual A, et al. (2005). Risk-factors for the acquisition of imipenem-resistant Acinetobacter bauman-nii in Spain: a nationwide study. Clin Microbiol Infect, 11: 874-79.
19. Prashanth K, Badrinath S (2006). Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Ind J Med Microbiol, 24: 39-44.